Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 is a research paper published in PLoS Computational Biology (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
King's Health Partners
Grant: King’s Together Rapid COVID-19 Call
Wellcome Trust
Grant: 213984/Z/18/Z
Wellcome Trust
Grant: 106223/Z/14/Z
Wellcome Trust
Grant: 222433/Z/21/Z
Medical Research Council
Grant: MR/W005611/1
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
National Institute of Allergy and Infectious Diseases
Grant: AI076119
EMBO
Grant: ALTF 663-2016
Asthma UK
Grant: Asthma UK Centre in Allergic Mechanisms of Asthma
Wellcome Trust
Grant: unidentified
unidentified
Wellcome Trust
Grant: 106223
Interferon and MX2 Mediated Control of HIV-1.
Wellcome Trust
Grant: 213984
The role of NMD/RNA decay in rhinovirus-mediated asthma exacerbations
Wellcome Trust
Grant: 222433
Interferon and Human Pandemic Viruses
National Institutes of Health
Grant: 2R01AI076119-06A1
Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIV
FWCI
1.86
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals